Mucosal adjuvants comprising an oligonucleotide and a cationic lipid

Details for Australian Patent Application No. 2002340662 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 60/379,343 10.05.02 US; 60/337,522 07.11.01 US

24 July 2003 Application Open to Public Inspection

Published as AU-B-2002340662

10 January 2008 Assignment before Grant

Inex Pharmaceuticals Corporation The application has been assigned to Tekmira Pharmaceuticals Corporation Assignments before Grant, Section 113

3 July 2008 Application Accepted

Published as AU-B-2002340662

30 October 2008 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.